DDIT4 and uveal melanoma: Physiologically, we demonstrate that DDIT4 overexpression or pharmacological inhibition of mTORC1 effectively abrogates the oncogenic potential of serum-unresponsive uveal melanoma cells, which commonly originate from mutations in G protein-coupled receptor (GPCR)-encoding genes33,34.